Table 2 of
Abu-Amero, Mol Vis 2011; 17:2171-2176. Table 2 of
Abu-Amero, Mol Vis 2011; 17:2171-2176.
Table 2. mtDNA haplogroup distribution in PACG patients and controls.
Haplogroup |
Coding positions |
PACG (n=227) |
HMS (n=186) |
HSA (n=810) |
PACG * HMS p value |
PACG * HSA p value |
|---|---|---|---|---|---|---|
| H | C7028C | 14 (6.2%) | 9 (4.8%) | 66 (8.1%) | 0.56 | 0.32 |
| R0a | T3847C | 51 (22.5%) | 26 (14.0%) | 141 (17.4%) | 0.03* | 0.08 |
| J | T4216C, C15452A | 64 (28.2%) | 47 (25.3%) | 171 (21.1%) | 0.51 | 0.02* |
| T | T4216C, G15928A | 11 (4.8%) | 9 (4.8%) | 53 (6.5%) | 0.99 | 0.35 |
| K | A3480G | 8 (3.5%) | 4 (2.2%) | 27 (3.3%) | 0.41 | 0.89 |
| U | A12308G, G12372A | 14 (6.2%) | 25 (13.4%) | 91 (11.2%) | 0.01* | 0.02* |
| Other R | C12705T | 6 (2.6%) | 8 (4.3%) | 25 (3.1%) | 0.35 | 0.73 |
| N1 | T10238C, G12501A | 12 (5.3%) | 13 (7.0%) | 66 (8.1%) | 0.47 | 0.15 |
| W | G15884C | 1 (0.4%) | 0 | 6 (0.7%) | 0.37 | 0.63 |
| X | C6371T | 8 (3.5%) | 4 (2.2%) | 20 (2.5%) | 0.41 | 0.39 |
| M1 | C10400T C12403T | 6 (2.6%) | 11 (5.9%) | 25 (3.1%) | 0.10 | 0.73 |
| M(xM1)1 | C10400T | 4 (1.8%) | 6 (3.2%) | 24 (3.0%) | 0.34 | 0.32 |
| L | T9540C, C10400C | 28 (12.3%) | 24 (12.9%) | 95 (11.7%) | 0.86 | 0.80 |
| L2 | T10115C | 16 (7.0%) | 10 (5.4%) | 35 (4.3%) | 0.49 | 0.09 |
| L(xL2)2 | T9540C, C10400C | 12 (5.3%) | 14 (7.5%) | 60 (7.4%) | 0.35 | 0.27 |